Chimera Investment Corporation  

(Public, NYSE:CIM)   Watch this stock  
Find more results for CIM
13.82
-0.01 (-0.04%)
Sep 2 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 11.92 - 17.02
Open     -
Vol / Avg. 0.00/2.03M
Mkt cap 2.84B
P/E 5.01
Div/yield 0.48/13.89
EPS 2.76
Shares 205.58M
Beta 0.82
Inst. own 59%
Nov 9, 2015
Q3 2015 Chimera Investment Corp Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Sep 23, 2015
Chimera Investment Corp Annual Shareholders Meeting (Estimated) - 3:00PM EDT - Add to calendar
Aug 6, 2015
Q2 2015 Chimera Investment Corp Earnings Call
Aug 5, 2015
Q2 2015 Chimera Investment Corp Earnings Release
Jun 24, 2015
Chimera Investment Corp at Deutsche Bank Mortgage REIT One-on-One Day
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin 53.84% 85.67%
Operating margin 53.84% 85.67%
EBITD margin - 73.95%
Return on average assets 2.82% 4.52%
Return on average equity 13.39% 16.98%
CDP Score - -

Address

1211 Avenue of the Americas Ste 2902
NEW YORK, NY 10036-8705
United States - Map
+1-212-6960100 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Chimera Investment Corporation is a specialty finance company. The Company, through its subsidiaries, invests in residential mortgage-backed securities (RMBS), residential mortgage loans, commercial mortgage loans, real estate-related securities and various other asset classes. The Company is externally managed by Fixed Income Discount Advisory Company.

Officers and directors

Matthew Lambiase President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Robert Colligan Chief Financial Officer
Age: 43
Bio & Compensation  - Reuters
Choudhary Yarlagadda Chief Operating Officer
Bio & Compensation  - Reuters
Mohit Marria Chief Investment Officer
Age: 37
Bio & Compensation  - Reuters
Phillip J. Kardis II General Counsel
Bio & Compensation  - Reuters
William B. Dyer Head - Underwriting
Age: 68
Bio & Compensation  - Reuters
Paul Donlin Non-Executive Independent Chairman of the Board
Age: 53
Bio & Compensation  - Reuters
Mark Abrams Independent Director
Age: 66
Bio & Compensation  - Reuters
Gerard Creagh Independent Director
Age: 56
Bio & Compensation  - Reuters
Paul A. Keenan Independent Director
Age: 48
Bio & Compensation  - Reuters